Part of Phaidon International![]()
Showing 210 results
Sort by:
Sr Oncology Consultant (Solid Tumor) - San FranciscoAbout the CompanyA growing commercial-stage biopharmaceutical company is seeking talented individuals to help advance innovative therapies for patients with serious diseases and high unmet medical needs. Backed by a strong global foundation, the organization has experienced rapid growth in the U.S...
Director, Business DevelopmentGreater Boston Area, MA About the OpportunityOur client, a growing life sciences organization, is seeking a Director, Business Development to lead commercial growth initiatives across a key U.S. territory.This is a strategic player-coach leadership role, combining individual business development responsibilities with ...
Senior Specialist, Clinical Safety $130,000-$140,000 Remote (USA) Reporting to Clinical Safety leadership, the Senior Specialist, Clinical Safety will support the safety oversight of multiple ongoing clinical studies for innovative cardiovascular medical devices. This individual will independently manage a high volume of concurrent safety activitie...
Take the first step toward your next opportunity - submit your resume and get started today.

Pharmaceutical Sales Representative | Rare Disease (Endocrinology) | New YorkA growing specialty pharmaceutical organization is seeking a Pharmaceutical Sales Representative to join its Rare Disease commercial team covering the Brooklyn and Queens territory.In this role, you will build and maintain relationships with endocrinologists, specialty pr...
Head of Regulatory Affairs Clinical-stage biotech | Flexible / Remote (US)We're partnering with an innovative clinical-stage biotech developing novel therapies in areas of significant unmet medical need. As early programs move into the clinic, the company is looking for a hands-on regulatory leader to own strategy from the ground up.The opportunity...
Regional Sales DirectorEPM Scientific is partnering with a rapidly growing biotechnology company following the FDA approval and U.S. launch of a breakthrough first-in-class therapy in dermatology and autoimmune disease.The approval represents a major inflection point for the business. The company is now investing in a broader commercial expansion ...